Physician profile
Carrie E Robertson
NPI 1609888270
$10,863.59
in general payments reported to CMS, 2019-2025
8 companies · $3,727 in 2025
The $3,727 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,709 · 2021: $46.13 · 2022: $39.41 · 2023: $230 · 2024: $112 · 2025: $3,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,681 · Travel and Lodging: $711 · Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,680.71 |
| Travel and Lodging | $711.03 |
| Food and Beverage | $677.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $9,327.66 | 2019-2025 | Vyepti |
| Abbvie INC. | $1,388.33 | 2023-2025 | Qulipta |
| Biodelivery Sciences International, INC. | $46.13 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.41 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $34.32 | 2019 | |
| Novo Nordisk INC | $27.74 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.